Ludicrous,mkt cap of 2.5m ,cash of 1m fully funded for over a year if warrants exercised8 May 2020 21:07
Dr Satu Vanikka, CEO of ValiRx Plc, commented:
"With prostate cancer reported this month in an academic study as being the most common cancer in men in the UK* and with an estimated 1.3 million new cases of prostate cancer occurring worldwide last year**, it is truly exciting to see VAL201 approaching the conclusion of its Phase I/II first-in-man study."